Similar Search Results

The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997 - 2010 : evidence from longitudinal, disease-level data

Lichtenberg, Frank R.; Pettersson, Billie - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 239-273

Persistent link: https://www.econbiz.de/10010407486

Technical change, learning, and wages

Bartel, Ann; Lichtenberg, Frank R. - 1988

Persistent link: https://www.econbiz.de/10000757843

The long-run impact of new medical ideas on cancer survival and mortality

Lichtenberg, Frank R. - 2018

Persistent link: https://www.econbiz.de/10011980353

Sources of US longevity increase, 1960 - 1997

Lichtenberg, Frank R. - 2002

Persistent link: https://www.econbiz.de/10001646748

Sources of U.S. longevity increase, 1960 - 1997

Lichtenberg, Frank R. - 2000

fluctuations as the consequence of fluctuations in medical inputs (expenditure) and technology. We estimate longevity models using …and medical innovation. Reliable annual data are available for only one type of innovation - new drugs - but … for the hypothesis that both medical innovation (in the form of new drug approvals) and expenditure on medical care …